Ardelyx

FDA approves Ardelyx's kidney disease-related drug
Reuters
Tue, 10/17/23 - 09:59 pm
Ardelyx
chronic kidney disease
FDA
Xphozah
FDA grants appeal for Ardelyx chronic kidney disease drug after July 2021 rejection
Endpoints
Fri, 12/30/22 - 10:40 am
Ardelyx
chronic kidney disease
FDA
tenapanor
In surprise turn, FDA adcomm votes in favor of Ardelyx CKD drug despite agency questions
Endpoints
Wed, 11/16/22 - 11:30 pm
Ardelyx
FDA
chronic kidney disease
tenapanor
ASN to Spotlight Debate around Ardelyx's Embattled CKD Drug
BioSpace
Tue, 11/1/22 - 11:56 am
Ardelyx
FDA
tenapanor
chronic kidney disease
Ardelyx amends license deal with Kyowa Kirin for tenapanor
Pharmaceutical Business Review
Tue, 04/12/22 - 10:40 am
Ardelyx
Kyowa Kirin
tenapanor
FDA denies Ardelyx’s appeal against kidney drug rejection, hammering another nail in tenapanor’s coffin
Fierce Biotech
Thu, 02/10/22 - 10:30 am
Ardelyx
FDA
complete response letter
tenapanor
chronic kidney disease
Ardelyx Prepares for Battle with FDA Over Rejected CKD Drug
BioSpace
Sun, 11/7/21 - 10:47 pm
Ardelyx
chronic kidney disease
tenapanor
FDA
Ardelyx axes 65% of workforce with no clarity from FDA on kidney drug's future
Fierce Pharma
Wed, 10/13/21 - 10:53 pm
Ardelyx
layoffs
chronic kidney disease
Ardelyx chops a third of its staff after stock-crushing failure in chronic kidney disease
Endpoints
Wed, 08/4/21 - 11:00 am
Ardelyx
chronic kidney disease
layoffs
tenapanor
FDA turns down Ardelyx’s chronic kidney disease drug and asks for another trial
MedCity News
Thu, 07/29/21 - 11:06 pm
Ardelyx
tenapanor
FDA
chronic kidney disease
Ardelyx’s ambition to revolutionize kidney treatment
Pharmaforum
Thu, 12/17/20 - 11:07 am
Ardelyx
tenapanor
hyperphosphatemia
Ardelyx's kidney disease drug hits goal in phase 3, teeing it up for FDA filing
Fierce Biotech
Tue, 12/3/19 - 10:29 am
Ardelyx
chronic kidney disease
tenapanor
clinical trials
Ardelyx bags its first FDA OK for IBS, setting up a showdown with Allergan, Ironwood
Endpoints
Sun, 09/15/19 - 09:45 pm
Ardelyx
Ibsrela
tenapanor
IBS-C
FDA
Ardelyx eyes first drug approval after decade-long journey
Bizjournals
Thu, 09/12/19 - 10:20 am
Ardelyx
tenapanor
IBS-C
FDA
Mark Your Calendar For These September PDUFA Dates
Yahoo/Benzinga
Wed, 08/28/19 - 12:53 pm
FDA
Roche
Celgene
Tecentriq
Xeris Pharmaceuticals
Gvoke
Ardelyx
tenapanor
Merck
Pifeltro
Delstrigo
Novo Nordisk
semaglutide
JNJ
Genmab
daratumumab
Invokana
Ardelyx Announces $50 Million Stock Offering
CP Wire
Wed, 05/23/18 - 09:44 am
Ardelyx
tenapanor
stock offering
Ardelyx Announces $50 Million Stock Offering
Tue, 05/22/18 - 08:57 pm
Ardelyx
Ardelyx scraps late-stage drug in another pipeline setback
BioPharma Dive
Fri, 11/24/17 - 11:27 am
Ardelyx
RDX7675
hyperkalemia
3 Biotech Stocks That Soared This Week: Are They Buys?
Motley Fool
Sun, 10/15/17 - 12:38 pm
biotech
AnaptysBio
Sorrento Therapeutics
Ardelyx
These 5 Biotech Stocks Under $10 Are About to Break Out
TheStreet.com
Fri, 04/1/16 - 09:23 am
biotech
Ardelyx
Biocryst
Affimed
Adaptimmune
Sangamo BioSciences

Pages